Skip to content
Screener

Talphera, Inc. TLPH Shares (Diluted)

Discontinued — last reported Q4 '23

Shares (Diluted) at other companies

Baxter International logo
Baxter InternationalBAX
515M+0.2%
AMP
Amphastar PharmaceuticalsAMPH
44.2M-8.1%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
88.3M+2.4%
Royalty Pharma logo
Royalty PharmaRPRX
556.9M-1.0%
PTH
Pelthos TherapeuticsPTHS
3.3M+440%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
61.3M+8.9%

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$74.22M+762%
P/S74,216.5×+73,898×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Talphera, Inc.’s 10-K, filed March 6, 2024.

Filed
Mar 6, 2024
Fiscal year
FY2023
Accession
0001437749-24-006849
Line itemYear Ended December 31, 2023Year Ended December 31, 2022
Loss from discontinued operations$(0.57)$(1.54)
Net (loss) income per share$(1.29)$5.73
Diluted (loss) earnings per share
(Loss) income from continuing operations$(0.72)$7.25
Loss from discontinued operations$(0.57)$(1.53)
Net (loss) income per share$(1.29)$5.72
Shares used in computing net (loss) income per share of common stock, basic – See Note 1214,263,7447,385,348
Shares used in computing net (loss) income per share of common stock, diluted – See Note 1214,263,7447,406,986

Item 16. Form 10-K Summary

FAQ

What is Talphera, Inc.'s shares (diluted)?
Talphera, Inc. (TLPH) reported shares (diluted) of 14.3M in Q4 2023.
How has Talphera, Inc.'s shares (diluted) changed year-over-year?
Talphera, Inc.'s shares (diluted) increased by 92.6% year-over-year, from 7.4M to 14.3M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Talphera, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude